The viral vector vaccine VSV-GP boosts immune response upon repeated applications

por Tober, R, Banki, Z, Ejaz, A, Muik, A, Egerer, L, von Laer, D, Kimpel, J
Publicado 2012

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity

por Hörl, S, Bánki, Z, Huber, G, Ejaz, A, Windisch, D, Muellauer, B, Willenbacher, E, Steurer, M, Stoiber, H
Publicado 2013

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity

por Hörl, S, Bánki, Z, Huber, G, Ejaz, A, Windisch, D, Muellauer, B, Willenbacher, E, Steurer, M, Stoiber, H
Publicado 2013